Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.040
-0.060 (-5.45%)
At close: Apr 1, 2025, 4:00 PM
1.098
+0.058 (5.60%)
After-hours: Apr 1, 2025, 7:28 PM EDT

Silexion Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2013 FY 2012
Period Ending
Dec '13 Dec '12
Net Income
-1.36-0.94
Depreciation & Amortization
00
Stock-Based Compensation
0.420.04
Change in Accounts Receivable
0.06-0.1
Change in Accounts Payable
0.020.06
Change in Other Net Operating Assets
0.050.03
Operating Cash Flow
-0.79-0.91
Capital Expenditures
-0.01-0
Other Investing Activities
-0.01-0.03
Investing Cash Flow
-0.02-0.03
Issuance of Common Stock
-1.72
Financing Cash Flow
-1.72
Net Cash Flow
-0.810.78
Free Cash Flow
-0.8-0.91
Free Cash Flow Per Share
-48.23-64.06
Levered Free Cash Flow
-0.31-
Unlevered Free Cash Flow
-0.3-
Change in Net Working Capital
-0.12-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q